Viewing nowDiorban Tablet 160mg (Valsartan)
Valsartan 160mg
Tablet · Prescription medication
Allico Pharmaceutical Co., Ltd.

MFDS item code 201706128 · Approved 2017.07.21 · Insurance code 656004660
Treatment of essential hypertension and heart failure; reduction of the risk of death after myocardial infarction
This medication is used for essential hypertension and heart failure, particularly in patients with heart failure who are intolerant to ACE inhibitors. It also helps reduce the risk of mortality in clinically stable patients with left ventricular failure or left ventricular systolic dysfunction after myocardial infarction. Therefore, it is effectively used for hypertension management, improvement of heart failure symptoms, and enhancement of safety after myocardial infarction.
1. Essential hypertension Take with water during or between meals. It is recommended that the medicine be taken at the same time each day, if possible (e.g., in the morning). 1) Adults: Regardless of sex or race, the recommended dose is 80 mg of valsartan orally once daily. The blood pressure-lowering effect develops gradually within 2 weeks and reaches its maximum effect after 4 weeks. For patients whose blood pressure is not adequately controlled, the dose may be increased to 160 mg once daily or a diuretic may be added. If further blood pressure reduction is needed, the dose may be increased to a maximum of 320 mg/day. 2) Elderly patients (75 years and older): Start treatment with 40 mg once daily. 3) Patients with renal impairment: (1) Creatinine clearance 20 ∼ 50 mL/min: No dose adjustment is necessary. (2) Creatinine clearance 10 ∼ 20 mL/min: Start treatment with 40 mg once daily. (3) Creatinine clearance below 10 mL/min and patients on dialysis: Do not administer this medicine. 4) Patients with volume depletion: In patients with volume depletion (e.g., patients taking high doses of diuretics whose dose cannot be reduced), start treatment with 40 mg once daily. 5) Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, start treatment with 40 mg once daily; do not exceed 80 mg/day. Do not administer this medicine to patients with severe hepatic impairment, cirrhosis, or cholestasis. 2. Heart failure Adults: The recommended starting dose is 40 mg orally twice daily; the dose may be increased to 80 mg or 160 mg per dose. When administered concomitantly with a diuretic, a reduction in the diuretic dose should be considered. The maximum daily dose is 320 mg, given in divided doses. Triple combination therapy with this medicine, an ACE inhibitor, and a beta-blocker is not recommended. 3. Reduction of the risk of death after myocardial infarction Adults: Treatment may be initiated within 12 hours of the onset of myocardial infarction. The recommended starting dose is 20 mg twice daily, after which the dose may be increased over several weeks to 40 mg, 80 mg, and 160 mg per dose twice daily, taking the patient's tolerability into account. Consider dose reduction if symptoms of hypotension or renal failure occur. This medicine may also be administered to patients receiving other treatments after myocardial infarction (e.g., thrombolytics, acetylsalicylic acid, beta-blockers, and statins). However, concomitant use with an ACE inhibitor is not recommended. 4. Patients with renal impairment: No dose adjustment is necessary if creatinine clearance is 10 mL/min or greater. However, use in patients with creatinine clearance below 10 mL/min or in patients on dialysis is not recommended because there is no experience of use in these patients. 5. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose should preferably not exceed 80 mg. If doses of 80 mg/day or higher are administered, consider whether the benefits of treatment outweigh the risks when increasing the dose. Do not administer this medicine to patients with severe hepatic impairment, cirrhosis, or cholestasis.
Children and adolescents under 18 years of age: Safety and efficacy have not been established. Children and adolescents under 18 years of age: Safety and efficacy have not been established.
This medication can cause serious harm to the fetus if taken during pregnancy, especially during the second and third trimesters; therefore, it should be discontinued immediately upon confirmation of pregnancy. Patients with an allergic reaction to this medication, pregnant or nursing women, patients with severe liver or kidney disease, and patients with a history of hereditary angioedema should not take this medication. Caution is advised for elderly patients, patients with high potassium levels, and patients with mildly impaired liver function, as this medication may lower blood pressure too much, so the dosage should be increased slowly. During the use of this medication, side effects such as dizziness, fatigue, headache, cough, diarrhea may occur, and rarely severe allergic reactions or renal function decline. In case of abnormal symptoms, immediate consultation with healthcare professionals is necessary. If blood pressure drops rapidly, use should be discontinued, and appropriate treatment should be sought, especially in patients taking diuretics or with fluid depletion. This medication may interact when taken with other antihypertensives or potassium-sparing diuretics, and nonsteroidal anti-inflammatory drugs (NSAIDs), so patients should inform healthcare professionals of all medications currently being taken. Women who are pregnant or planning to become pregnant should not take this medication, and nursing mothers are also advised to avoid this medication. It is recommended not to use this medication in children and adolescents under 18 years of age, as its safety and efficacy have not been established. In case of overdose, severe hypotension and decreased consciousness may occur, requiring immediate medical treatment, and vomiting or hemodialysis will not be helpful. This medication should be kept out of reach of children, and transferring it to other containers is discouraged to maintain quality. Regular monitoring of blood pressure, renal function, and serum potassium levels during the use of this medication is important to ensure there are no abnormalities.
headache
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and humidity; therefore, it should be stored in a tightly sealed container. Additionally, it should be kept in a cool place below 30 degrees Celsius to maintain its effectiveness.
Oval film-coated tablet with an orange color and grayish tint
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowValsartan 160mg
Tablet · Prescription medication
Allico Pharmaceutical Co., Ltd.

Valsartan 80mg
Tablet · Prescription medication
Novartis Korea Co., Ltd.

Valsartan 160mg
Tablet · Prescription medication
Novartis Korea Co., Ltd.

Valsartan 40mg
Tablet · Prescription medication
Samsung Novartis Co., Ltd.
Valsartan
Prescription medication
Korea Sandos Co., Ltd.
Valsartan
Prescription medication
Korea Sandos Co., Ltd.

Valsartan
Prescription medication
Korea Sandos Co., Ltd.

Valsartan 320mg
Tablet · Prescription medication
Novartis Korea Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.